Prescription and Over-the-Counter Pharmaceuticals
Humanity has but three great enemies: fever, famine and war…by far the most terrible is fever.
Ehrreich Consulting offers insider expertise in drug development and the FDA approval process, with the added benefit of a former FDA Deputy Division Director of cardio-renal drugs, Dr. Stewart Ehrreich. Our extended team consists of experts in drug chemistry, pharmacokinetics, clinical trial design, statistics and biostatistics. Whether assisting with a prescription (℞) drug or an over-the-counter (OTC) medication, we provide our regulatory consulting services to a variety of pharmaceutical companies, from family-owned start-ups to major multinational firms.
Our pharmaceutical consulting firm has experience with every part of the Drug Lifecycle, from discovery and selection to post-marketing strategies. We routinely evaluate preclinical and clinical protocols, raw data, and finalized reports. Our formulation of regulatory strategies, including FDA interaction and coordination, has been time-tested and proven successful. Ehrreich Consulting prevents potential regulatory roadblocks in drug development and solves regulatory problems in all stages from discovery to approval and beyond.
We have worked on a vast array of projects led by our Project Manager, Mr. Benjamin Rawlings. From neuro-oncological drugs to dermatologics, topical non-steroidal anti-inflammatories (NSAIDs) to antidepressants, and new chemical entities to combination drugs, Ehrreich Consulting has seen and done it all. We have been instrumental in securing the FDA approval of drugs for treatment of everything from chronic obstructive pulmonary disease (COPD) to hypothyroidism.
Additional strength can be found in our flexibility, with a virtual team of scientific and regulatory experts working around the United States. We provide each individual client with exactly the level of interaction required for their prescription or OTC drug, from a very hands-on participation to a completely turnkey approach. As regulatory consultants with a strong FDA background, we have worked closely with the Agency on a long-term basis to help our clients obtain FDA approval for their pharmaceutical products.